Source: International Congress 2014 – Direct and indirect monitoring of comorbidities
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Tina, P. Georgantas, E. Iliopoulou, P. Andriopoulos (Sparta, Greece). Diabetes mellitus and obstructive pulmonary disease. Is there an association?. Eur Respir J 2014; 44: Suppl. 58, 2938

Member's Comments

No comment yet.

Related content which might interest you: Clinical presentation of chronic obstructive pulmonary disease (COPD): Study on-sint Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014 Frequency of depression in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes? Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Clinical factors linked with coronary artery disease in chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Assessment of patients preferences regarding characteristics associated with treatment of chronic obstructive pulmonary disease Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Chronic obstructive pulmonary disease (COPD) and alterations of hemogram Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 High prevalence of undiagnosed airflow obstruction in patients with ischaemic heart disease Source: International Congress 2014 – Direct and indirect monitoring of comorbidities Year: 2014 Pulmonary hypertension (PH) in chronic obstructive pulmonary disease (COPD): Preliminary data of a longitudinal survey Source: International Congress 2014 – Clinical presentations Year: 2014 Chronic obstructive pulmonary disease and comorbidities Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Pulmonary hypertension and COPD: Clinical assessment and biomarkers Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 The metabolic syndrome in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Characteristics of pulmonary function of COPD with and without arterial pulmonary hypertension Source: International Congress 2014 – Comorbidities Year: 2014 Diabetes and hospitalization for COPD exacerbation Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Pulmonary hypertension correction in patients with chronic obstructive pulmonary disease and essential hypertension Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Severity of airway obstruction in overweight/obese patients with chronic obstructive pulmonary disease(COPD) Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Associations between muscle wasting and BODE index in chronic obstructive pulmonary disease Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Prognostic significance of neutrophil to lymphocyte ratio in chronic obstructive pulmonary disease Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Case-finding options for COPD: results from the Burden of Obstructive Lung Disease Study Source: Eur Respir J 2013; 41: 548-555 Year: 2013 Anemia in patients with chronic obstructive pulmonary disease - Association with comorbidities Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Anemia in COPD patients of Korean obstructive lung disease (KOLD) cohort Source: International Congress 2015 – Multidimensional analysis of respiratory problems Year: 2015